| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/25/1995 | EP0635030A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/$i(neu)) RELATED SURFACE ANTIGENS |
| 01/25/1995 | EP0635019A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels |
| 01/25/1995 | EP0635016A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof |
| 01/25/1995 | EP0635013A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
| 01/25/1995 | EP0635000A1 Novel phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels |
| 01/25/1995 | EP0634999A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels |
| 01/25/1995 | EP0634939A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 01/25/1995 | EP0634938A1 Immunotoxins directed against cd33 related surface antigens |
| 01/25/1995 | EP0634936A1 Materials and methods for immunocontraception |
| 01/25/1995 | EP0634934A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/24/1995 | US5384395 Method for the isolation of primary-toxic compounds or allergens from plant material |
| 01/24/1995 | US5384122 Herpesvirus particles and vaccine |
| 01/24/1995 | US5383847 Non-specific immune system enhancement |
| 01/24/1995 | CA1334076C Monoclonal antibody recognizing atrial natriuretic polypeptide |
| 01/23/1995 | CA2128285A1 Monoclonal antibodies against prostate specific antigen that are not available in psa complexed to 1-antichymotrypsin |
| 01/20/1995 | CA2128151A1 Receptors of interleukin-12 and antibodies |
| 01/19/1995 | WO1995002065A1 Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| 01/19/1995 | WO1995002057A1 Protein tyrosine kinase and ligands thereof |
| 01/19/1995 | WO1995002054A2 Platelet glycoprotein v gene and uses |
| 01/19/1995 | WO1995002052A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
| 01/19/1995 | WO1995002048A1 Salmonella vaccines |
| 01/19/1995 | WO1995001995A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 01/19/1995 | WO1995001806A1 Pro-cytotoxic drug conjugates for anticancer therapy |
| 01/19/1995 | WO1995001805A1 Bloody swine dysentery vaccine and vaccination kit therefor |
| 01/19/1995 | WO1995001802A1 Growth differentiation factor-7 |
| 01/19/1995 | WO1995001801A1 Growth differentiation factor-6 |
| 01/19/1995 | WO1995001800A1 Cyclic semi-random peptide libraries |
| 01/19/1995 | WO1994026891A3 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 01/19/1995 | WO1994006345A3 Immunosorbent for use in the diagnosis of neuro-psychological disorders, and use thereof |
| 01/19/1995 | CA2166872A1 Platelet glycoprotein v gene and uses |
| 01/19/1995 | CA2166798A1 Pro-cytotoxic drug conjugates for anticancer therapy |
| 01/19/1995 | CA2166787A1 Salmonella vaccines |
| 01/19/1995 | CA2165778A1 Growth differentiation factor-7 |
| 01/19/1995 | CA2165776A1 Growth differentiation factor-6 |
| 01/19/1995 | CA2141417A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
| 01/18/1995 | EP0634408A1 Depsipeptide derivative, production thereof and use thereof |
| 01/18/1995 | EP0634161A1 Hair dye or cosmetic material, pretreatment agent and hair dyeing method |
| 01/18/1995 | EP0633942A1 Non-infectious hiv particles and uses therefor |
| 01/18/1995 | EP0633937A1 Immunization by inoculatioon of dna transcription unit |
| 01/18/1995 | EP0633931A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 01/18/1995 | EP0633930A1 In vitro generation of human dendritic cells and uses thereof |
| 01/18/1995 | EP0633929A1 METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS |
| 01/18/1995 | EP0633894A1 Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification |
| 01/18/1995 | EP0633785A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 01/18/1995 | EP0406316B1 Peptides derived from Foot and mouth disease virus |
| 01/17/1995 | US5382657 Peg-interferon conjugates |
| 01/17/1995 | US5382509 Method and kit for the diagnosis of human papillomavirus type 41 |
| 01/17/1995 | US5382435 Microparticulate pharmaceutical delivery system |
| 01/17/1995 | US5382428 Method for preparing a purified extraction residue fraction and its use in stimulating the immune response |
| 01/17/1995 | US5382425 Recombinant swinepox virus |
| 01/17/1995 | CA2128175A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy |
| 01/12/1995 | WO1995001568A1 Immunoassay for soluble fibrin polymers |
| 01/12/1995 | WO1995001445A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 01/12/1995 | WO1995001442A2 Nucleotide and amino acid sequences of the envelope 1 gene of 51 hepatitis c virus isolates and the use of reagents derived therefrom as diagnostic reagents and vaccines |
| 01/12/1995 | WO1995001441A1 Tuberculosis vaccine |
| 01/12/1995 | WO1995001440A1 Diagnostic skin test for tuberculosis |
| 01/12/1995 | WO1995001436A1 Conotoxins having acetylcholin receptor binding properties |
| 01/12/1995 | WO1995001375A1 Inhibitor of collagen-stimulated platelet aggregation |
| 01/12/1995 | CA2166401A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 01/12/1995 | CA2166386A1 Immunoassay for soluble fibrin polymers |
| 01/11/1995 | EP0633313A1 Vaccine against lyme disease |
| 01/11/1995 | EP0633029A2 Further improvements relating to drug delivery systems |
| 01/11/1995 | EP0633028A1 Vaccine against lyme disease |
| 01/11/1995 | EP0632834A1 Microorganisms having attenuated invasiveness |
| 01/11/1995 | EP0632816A1 PEPTIDE SEQUENCE CAPABLE OF INDUCING A DELAYED-TYPE HYPERSENSITIVITY REACTION IN THE PRESENCE OF $i(MYCOBACTERIUM TUBERCULOSIS) COMPLEX LIVING BACTERIA, AND APPLICATIONS |
| 01/11/1995 | EP0632814A1 High molecular weight surface proteines of non-typeable haemophilus |
| 01/11/1995 | EP0632729A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 01/11/1995 | EP0632727A1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 01/11/1995 | EP0362288B1 Expression of immunologically active proteins of human b-lymphotropic virus |
| 01/11/1995 | EP0362279B1 Saponin adjuvant |
| 01/11/1995 | EP0207090B1 Monoclonal antibodies and antigens for human non-small cell lung carcinomas |
| 01/11/1995 | CN1097142A Preparation method for tumor vaccine |
| 01/10/1995 | US5380927 Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl-propionic acids |
| 01/10/1995 | US5380655 Forming transformed Haemophilus influenzae cells used to make Haemophilus P2 antigen by transforming Haemophilus host cells with recombinant vector including DNA sequence encoding the antigen; selecting transformants expressing antigen; vector |
| 01/10/1995 | US5380648 Method for the diagnosis of virulent bacteria |
| 01/10/1995 | US5380513 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 01/10/1995 | CA2126819A1 Kit and method for pretargeting |
| 01/10/1995 | CA1333887C Immunity memory cell suspension and method of preparing same |
| 01/10/1995 | CA1333883C Immunoassay utilizing biotin bridge with universal solid phase |
| 01/05/1995 | WO1995000850A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
| 01/05/1995 | WO1995000849A1 Recombinant 170 kd subunit lectin of entamoeba histolytica and methods of use |
| 01/05/1995 | WO1995000670A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 01/05/1995 | WO1995000659A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/05/1995 | WO1995000658A1 COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
| 01/05/1995 | WO1995000649A1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/05/1995 | WO1995000648A1 Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection |
| 01/05/1995 | WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | WO1995000642A1 Vertebrate apoptosis gene: compositions and methods |
| 01/05/1995 | WO1995000552A1 Prostaglandin receptor ep3 and dna encoding it |
| 01/05/1995 | WO1995000551A1 Prostaglandin receptor fp and dna encoding it |
| 01/05/1995 | WO1995000545A1 Synthetic peptides for the detection of antibodies against the virus of hepatitis c in the serum of infected persons |
| 01/05/1995 | WO1995000540A1 Synthetic carrier and immunogen |
| 01/05/1995 | WO1995000178A1 Pore-forming and superantigen encoding toxin cassettes for gene therapy |
| 01/05/1995 | WO1995000173A1 Improvements in or relating to vaccine development |
| 01/05/1995 | WO1995000172A1 Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof |
| 01/05/1995 | WO1995000163A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/05/1995 | WO1994023059A3 Anti-microbial agents and screening method therefor |
| 01/05/1995 | WO1994021792A3 Inhibition of selected tumor growth with recombinant viral vectors |
| 01/05/1995 | WO1994018324A3 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |